We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$562M
AUM Growth
+$227M
Cap. Flow
+$212M
Cap. Flow %
37.82%
Top 10 Hldgs %
51.62%
Holding
194
New
19
Increased
129
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$22.2M
2
ETP
Energy Transfer Partners L.p.
ETP
+$22M
3
BPL
Buckeye Partners, L.P.
BPL
+$16.4M
4
ET icon
Energy Transfer Partners
ET
+$16.2M
5
WPZ
Williams Partners L.P.
WPZ
+$13.7M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.3M
2
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$2.47M
3
IDU icon
iShares US Utilities ETF
IDU
+$2.2M
4
IYE icon
iShares US Energy ETF
IYE
+$2.06M
5
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$1.95M

Sector Composition

Rank Sector Weight
1 Energy 69.83%
2 Healthcare 9.07%
3 Utilities 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
126
Kyntra Bio
KYNB
$28.5M
$339K 0.06%
550
+53
+11% +$32.3K
SIOX
127
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$333K 0.06%
2,788
+268
+11% +$28.1K
OMED
128
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$333K 0.06%
36,113
+3,462
+11% +$30.4K
ALNY icon
129
Alnylam Pharmaceuticals
ALNY
$36.3B
$332K 0.06%
6,478
+621
+11% +$28.7K
CYTK icon
130
Cytokinetics
CYTK
$11B
$320K 0.06%
24,879
+2,385
+11% +$27.9K
GERN icon
131
Geron
GERN
$911M
$311K 0.06%
137,195
+13,152
+11% +$28K
AGIO icon
132
Agios Pharmaceuticals
AGIO
$2.16B
$308K 0.05%
5,269
+505
+11% +$24.2K
PBYI icon
133
Puma Biotechnology
PBYI
$406M
$303K 0.05%
8,147
+781
+11% +$28.5K
NGNE icon
134
Neurogene
NGNE
$696M
$302K 0.05%
904
+87
+11% +$30.6K
ITCI
135
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$298K 0.05%
18,329
+1,757
+11% +$25.4K
PRTA icon
136
Prothena Corp
PRTA
$458M
$296K 0.05%
5,303
+508
+11% +$26.7K
FCH.PRA
137
DELISTED
Felcor Lodging Tr Ser A Cum Cv
FCH.PRA
$296K 0.05%
+12,128
New +$300K
IOVA icon
138
Iovance Biotherapeutics
IOVA
$2.23B
$294K 0.05%
39,420
+3,779
+11% +$27.7K
RETA
139
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$292K 0.05%
12,909
+1,237
+11% +$30.6K
ACHN
140
DELISTED
Achillion Pharmaceuticals
ACHN
$292K 0.05%
69,450
+6,658
+11% +$27.6K
ONCE
141
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$286K 0.05%
5,361
+514
+11% +$30.5K
ARRY
142
DELISTED
Array Biopharma Inc
ARRY
$286K 0.05%
32,023
+3,070
+11% +$32.7K
SGYP
143
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$285K 0.05%
61,108
+5,858
+11% +$34K
TCRT icon
144
Alaunos Therapeutics
TCRT
$4.74M
$283K 0.05%
298
+29
+11% +$27K
NBIX icon
145
Neurocrine Biosciences
NBIX
$17.7B
$280K 0.05%
6,475
+621
+11% +$26.6K
NVAX icon
146
Novavax
NVAX
$1.23B
$278K 0.05%
10,848
+1,040
+11% +$28.6K
KDNY
147
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$275K 0.05%
5,112
+490
+11% +$27.7K
MYOK
148
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$275K 0.05%
20,886
+2,002
+11% +$25.6K
CLDX icon
149
Celldex Therapeutics
CLDX
$2.77B
$272K 0.05%
5,016
+481
+11% +$25K
XNCR icon
150
Xencor
XNCR
$1.44B
$271K 0.05%
11,350
+1,088
+11% +$26.2K
4 5
6
7 8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Virtus ETF Advisers held 194 positions worth $562M, up 68% from $335M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Virtus ETF Advisers deployed $212M of net new capital in Q1 2017, opening 19 new positions and adding to 129 existing holdings. Its largest new stake was Kinder Morgan: 272,117 shares worth $5.92M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 57% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.3M trimmed.

  • Virtus ETF Advisers's largest Q1 2017 buy was Kinder Morgan: 272,117 shares worth $5.92M.
  • Virtus ETF Advisers added most to iShares 0-1 Year Treasury Bond ETF in Q1 2017, an estimated $22.2M increase.
  • Virtus ETF Advisers's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.3M.
  • Virtus ETF Advisers fully exited iShares Expanded Tech Sector ETF in Q1 2017, selling an estimated $2.47M.
  • Virtus ETF Advisers's ten largest holdings make up 52% of its $562M portfolio in Q1 2017.
  • Virtus ETF Advisers opened 19 new positions and closed 24 in Q1 2017.
  • Virtus ETF Advisers's portfolio value rose 68% quarter-over-quarter to $562M.

Based on Virtus ETF Advisers's 13F filing for Q1 2017, filed 15 May 2017.